Skip to main content
OpenTrials

Clinical trial condition

Neoplastic Processes

Explore clinical trials studying Neoplastic Processes. Study availability and eligibility vary by location and protocol.

3,266 public trials 688 recruiting studies
Refine in advanced search Browse all conditions

Neoplastic Processes trial results

Active, Not Recruiting

A Phase I/II, Dose Finding and Optimization Study of [177Lu]Lu-NeoB in Combination With Capecitabine in Patients With GRPR+, ER+, HER2- Metastatic Breast Cancer After Progression on Previous Endocrine Therapy in Combination With a CDK4/6 Inhibitor.

NCT06247995

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +8 more
Locations
  • UCLA Medical Center Los Angeles, California, United States
  • Hoag Memorial Hospital Presbyterian Newport Beach, California, United States
  • Mayo Clinic - Rochester Rochester, Minnesota, United States
  • Uni Of TX MD Anderson Cancer Cntr Houston, Texas, United States
View all 23 locations
View Trial Details
Active, Not Recruiting

Study of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy for HR+/HER2- Locally Recurrent Inoperable or Metastatic Breast Cancer (MK-3475-B49/KEYNOTE-B49)

NCT04895358

Conditions
Breast Diseases, Breast Neoplasms, Neoplasm Metastasis, +8 more
Locations
  • University of Alabama at Birmingham-Medicine ( Site 0065) Birmingham, Alabama, United States
  • Arizona Oncology Associates-Arizona Oncology ( Site 0049) Tucson, Arizona, United States
  • Pacific Cancer Care ( Site 0023) Monterey, California, United States
  • UCSF Medical Center at Mission Bay ( Site 0043) San Francisco, California, United States
View all 256 locations
View Trial Details
Active, Not Recruiting

Testing the PD-1 Antibody, MK3475, Given With Ziv-aflibercept in Patients With Advanced Cancer

NCT02298959

Conditions
Adenocarcinoma, Adnexal Diseases, Carcinoma, +60 more
Locations
  • Moffitt Cancer Center-International Plaza Tampa, Florida, United States
  • Moffitt Cancer Center - McKinley Campus Tampa, Florida, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • National Cancer Institute Developmental Therapeutics Clinic Bethesda, Maryland, United States
View Trial Details
Active, Not Recruiting

Malignant Pleural Disease Treated With Autologous T Cells Genetically Engineered to Target the Cancer-Cell Surface Antigen Mesothelin

NCT02414269

Conditions
Adenoma, Breast Cancer, Breast Diseases, +21 more
Locations
  • Memorial Sloan Kettering Basking Ridge (Consent and Follow-Up) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Consent and Follow-Up) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Consent and Follow-Up) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Commack (Consent and Follow-Up) Commack, New York, United States
View Trial Details
Active, Not Recruiting

A Study of Ramucirumab (LY3009806) or Merestinib (LY2801653) in Advanced or Metastatic Biliary Tract Cancer

NCT02711553

Conditions
Advanced Cancer, Biliary Tract Cancer, Biliary Tract Diseases, +10 more
Locations
  • The University of Arizona Cancer Center Tucson, Arizona, United States
  • UCSF Medical Center at Mission Bay San Francisco, California, United States
  • Georgetown University Medical Center Washington D.C., District of Columbia, United States
  • University of Florida School of Medicine Gainesville, Florida, United States
View all 82 locations
View Trial Details

Related conditions